Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from SPECIAL MTA: Novel Radiochemistry & Chelation Posters

  • You have access
    Novel TACN chelator: a scaffold designed for dual-receptor targeted PET imaging
    Yongkang Gai, Lingyi Sun, Guangya Xiang, Xiang Ma and Dexing Zeng
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1053;
  • You have access
    Effect of electron withdrawing groups at α-position of nitrophenyl styrene derivatives on nucleophilic aromatic 18F-fluorination
    Pulak Chakraborty, Sudha Garg and Pradeep Garg
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1046;
  • You have access
    Pb203-labeled radiotracers targeting metastatic melanoma - Optimization of labeling of DOTA- and TCMC-conjugates.
    Izabela Tworowska, Nilesh Wagh, Sanjay Thamake, Jessica Reedy, David Ranganathan, Ira Goldman, Martin Brechbiel, Michael Schultz and Ebrahim Delpassand
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1061;
  • You have access
    Radioarsenic-labeled mesoporous silica nanoparticles: A new theranostic platform.
    Paul Ellison, Feng Chen, Todd Barnhart, Robert Nickles, Weibo Cai and Onofre DeJesus
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1058;
  • You have access
    Microwave Assisted 18F-m-fluorobenzylguanidine (mFBG) Synthesis Using the ALP-mFBG™ Diaryliodonium Salt Precursor
    Alejandro Amor-Coarasa, James Kelly, Bao Hu, Kiel Neumann, Stephen DiMagno and John Babich
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1044;
  • You have access
    Design and synthesis of a Radiotracer for Noninvasive Imaging of Stearoyl-CoA Desaturase-1
    William Silvers, Hancheng Cai, Saleh Ramezani, Orhan Oz and Xiankai Sun
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1043;
  • You have access
    Novel strategy for radiolabelling polymeric micelles with a hydrophobic chelator for PET imaging
    Ana de la Fuente, Nicole Mohr, Frank Roesch and Rudolf Zentel
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1057;
  • You have access
    Evaluation of a novel small targeting agent 125I-CXCL10 for acute allorejection monitoring
    Dayan Cheng and Guihua Hou
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1065;
  • You have access
    55Co separation from deuteron-irradiated electrodeposited 54Fe targets
    Hector Valdovinos, Stephen Graves, Todd Barnhart and Robert Nickles
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1038;
  • You have access
    DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance in bone targeting radiotherapy: a new class of “DOTA-BPretard” tracers
    Marian Meckel, Nina Pfannkuchen, Matthias Miederer and Frank Rösch
    Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 1056;

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 13
SNMMI

© 2025 SNMMI

Powered by HighWire